Chengdu Guibao Science & TechnologyLtd Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Chengdu Guibao Science & TechnologyLtd wird ein jährliches Gewinn- und Umsatzwachstum von 30.9% bzw. 16.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 30.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.3% betragen.

Wichtige Informationen

30.9%

Wachstumsrate der Gewinne

30.7%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	39.9%
Wachstumsrate der Einnahmen	16.4%
Zukünftige Eigenkapitalrendite	14.3%
Analystenabdeckung	Low
Zuletzt aktualisiert	15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Stock Rockets 35% As Investors Are Less Pessimistic Than Expected

Nov 19

Chengdu Guibao Science & TechnologyLtd (SZSE:300019) May Have Issues Allocating Its Capital

Nov 08

Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Subdued P/E Might Signal An Opportunity

Sep 30

Is It Too Late To Consider Buying Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019)?

Aug 23

Downgrade: Here's How Analysts See Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Performing In The Near Term

Jun 16

Investors Still Aren't Entirely Convinced By Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Earnings Despite 26% Price Jump

Apr 09

Is Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Trading At A 29% Discount?

Mar 28

Should You Investigate Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) At CN¥14.50?

Mar 12

Gewinn- und Umsatzwachstumsprognosen

SZSE:300019 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	4,172	479	N/A	340	4
12/31/2025	3,755	363	N/A	417	3
12/31/2024	3,235	255	N/A	344	2
9/30/2024	2,826	250	16	230	N/A
6/30/2024	2,570	285	79	324	N/A
3/31/2024	2,549	300	175	401	N/A
12/31/2023	2,606	315	247	436	N/A
9/30/2023	2,588	308	379	533	N/A
6/30/2023	2,507	280	385	513	N/A
3/31/2023	2,556	263	239	353	N/A
12/31/2022	2,694	250	19	127	N/A
9/30/2022	2,893	272	14	115	N/A
6/30/2022	2,929	277	-68	29	N/A
3/31/2022	2,867	282	-53	38	N/A
1/1/2022	2,556	268	88	176	N/A
9/30/2021	2,263	228	-6	85	N/A
6/30/2021	1,988	223	61	143	N/A
3/31/2021	1,726	219	115	196	N/A
12/31/2020	1,524	201	151	222	N/A
9/30/2020	1,288	183	90	141	N/A
6/30/2020	1,145	159	88	127	N/A
3/31/2020	993	128	68	90	N/A
12/31/2019	1,018	132	60	82	N/A
9/30/2019	961	128	62	79	N/A
6/30/2019	914	99	42	60	N/A
3/31/2019	905	81	22	38	N/A
12/31/2018	871	65	52	68	N/A
9/30/2018	817	39	19	36	N/A
6/30/2018	784	44	N/A	57	N/A
3/31/2018	758	47	N/A	83	N/A
12/31/2017	728	52	N/A	92	N/A
9/30/2017	721	57	N/A	102	N/A
6/30/2017	708	72	N/A	101	N/A
3/31/2017	662	80	N/A	91	N/A
12/31/2016	652	91	N/A	78	N/A
9/30/2016	621	95	N/A	74	N/A
6/30/2016	613	93	N/A	60	N/A
3/31/2016	611	92	N/A	71	N/A
12/31/2015	606	89	N/A	66	N/A
9/30/2015	591	83	N/A	31	N/A
6/30/2015	585	83	N/A	42	N/A
3/31/2015	572	82	N/A	52	N/A
12/31/2014	549	80	N/A	45	N/A
9/30/2014	517	73	N/A	68	N/A
6/30/2014	499	71	N/A	52	N/A
3/31/2014	475	71	N/A	60	N/A
12/31/2013	465	70	N/A	56	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 300019Das prognostizierte Gewinnwachstum (30.9% pro Jahr) liegt über der Sparquote (2.8%).

Ertrag vs. Markt: 300019Die Erträge des Unternehmens (30.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt CN (26.3% pro Jahr).

Hohe Wachstumserträge: 300019Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: 300019Die Einnahmen des Unternehmens (16.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt CN (13.9% pro Jahr).

Hohe Wachstumseinnahmen: 300019Die Einnahmen des Unternehmens (16.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 300019Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.3%).

Chengdu Guibao Science & TechnologyLtd Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 27%, revenue upgraded

Consensus EPS estimates increase by 10%

Consensus revenue estimates fall by 15%

Price target decreased by 13% to CN¥18.20

Price target increased to CN¥25.83

Recent updates

New minor risk - Share price stability

Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Stock Rockets 35% As Investors Are Less Pessimistic Than Expected

Investor sentiment improves as stock rises 27%

Chengdu Guibao Science & TechnologyLtd (SZSE:300019) May Have Issues Allocating Its Capital

Consensus EPS estimates fall by 27%, revenue upgraded

Third quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.23 in 3Q 2023)

Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024

Investor sentiment improves as stock rises 30%

Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Subdued P/E Might Signal An Opportunity

Consensus EPS estimates increase by 10%

Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.20 in 2Q 2023)

Is It Too Late To Consider Buying Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019)?

Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024

Downgrade: Here's How Analysts See Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Performing In The Near Term

Consensus revenue estimates fall by 15%

Dividend of CN¥0.30 announced

Now 31% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 18%

Price target decreased by 13% to CN¥18.20

Investors Still Aren't Entirely Convinced By Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Earnings Despite 26% Price Jump

Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 20, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024

Is Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Trading At A 29% Discount?

Should You Investigate Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) At CN¥14.50?

Chengdu Guibao Science & Technology to Buy Hot Melt Adhesive Firm

Full year 2023 earnings released: EPS: CN¥0.81 (vs CN¥0.64 in FY 2022)

Investor sentiment deteriorates as stock falls 15%

Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 3Q 2022)

Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 19, 2023

Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.15 in 2Q 2022)

Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 12, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings released: EPS: CN¥0.64 (vs CN¥0.70 in FY 2021)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.17 in 3Q 2021)

Investor sentiment deteriorated over the past week

Price target increased to CN¥25.83

Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.17 in 2Q 2021)

Investor sentiment improved over the past week

Chengdu Guibao Science & Technology Co.,Ltd. Announces Board Appointments

Less than half of directors are independent

Chengdu Guibao Science & Technology Co.,Ltd. Proposes Cash Dividend on A Shares for the Year 2021, Payable on April 28, 2022

Chengdu Guibao Science & Technology Co.,Ltd. Approves 2021 Profit Distribution Plan

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 15, 2022

Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 15, 2022

Chengdu Guibao Science & Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

Investor sentiment deteriorated over the past week

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.19 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.19 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.081 (vs CN¥0.031 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.40 in FY 2019)

Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 27, 2021

New 90-day low: CN¥15.19

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: CN¥19.98

Third quarter earnings released

New 90-day high: CN¥18.00

Market bids up stock over the past week